Reply
Ibtesam Hilmi – 17 August 2015
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt – 14 August 2015 – Hepatocellular carcinoma (HCC) is increasingly reported in patients with nonalcoholic fatty liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with NAFLD‐HCC.
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt – 14 August 2015 – Hepatocellular carcinoma (HCC) is increasingly reported in patients with nonalcoholic fatty liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with NAFLD‐HCC.
Reply
Julio A. Gutierrez, Andres Carrion, Kalyan Ram Bhamidimarri, Adam L. Peyton – 13 August 2015
Liver receptor homolog‐1 is a critical determinant of methyl‐pool metabolism
Martin Wagner, Sungwoo Choi, Katrin Panzitt, Jennifer L. Mamrosh, Jae Man Lee, Alex Zaufel, Rui Xiao, Ruth Wooton‐Kee, Marcus Ståhlman, Christopher B. Newgard, Jan Borén, David D. Moore – 12 August 2015 – Balance of labile methyl groups (choline, methionine, betaine, and folate) is important for normal liver function. Quantitatively, a significant use of labile methyl groups is in the production of phosphatidylcholines (PCs), which are ligands for the nuclear liver receptor homolog‐1 (LRH‐1).
Fecal microbiota transplantation in the management of hepatic encephalopathy
Dina Kao, Brandi Roach, Heekuk Park, Naomi Hotte, Karen Madsen, Vince Bain, Puneeta Tandon – 11 August 2015
Fecal microbiota transplantation in the management of hepatic encephalopathy
Dina Kao, Brandi Roach, Heekuk Park, Naomi Hotte, Karen Madsen, Vince Bain, Puneeta Tandon – 11 August 2015
Research is needed on the difficult‐to‐cure population of hepatitis C virus patients with disability
Viktor Chirikov, Fadia Shaya, C. Daniel Mullins, Susan dosReis, Eberechukwu Onukwugha, Charles Howell – 11 August 2015
Impact of body mass index on posttransplant outcomes reexamined
Khurram Bari, Pratima Sharma – 11 August 2015
Once‐daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations
Audrey Coilly, Yvon Calmus, Faiza Chermak, Jerome Dumortier, Christophe Duvoux, Olivier Guillaud, Pauline Houssel‐Debry, Martine Neau‐Cransac, Jeanick Stocco – 11 August 2015 – The efficacy and safety of tacrolimus (Tac) twice daily (bid) and once a day (qd) formulations are considered to be similar. However, the available information regarding initiation of Tac qd is sparse, and practical information is lacking.